Search results
Results from the WOW.Com Content Network
Ketamine can be absorbed by many different routes due to both its water and lipid solubility. Intravenous ketamine bioavailability is 100% by definition, intramuscular injection bioavailability is slightly lower at 93%, [7] and epidural bioavailability is 77%. [9] Subcutaneous bioavailability has never been measured, but is presumed to be high ...
Therefore, bioavailability for dietary supplements can be defined as the proportion of the administered substance capable of being absorbed and available for use or storage. [11] In both pharmacology and nutrition sciences, bioavailability is measured by calculating the area under curve (AUC) of the drug concentration time profile.
Esketamine, sold under the brand names Spravato (for depression) and Ketanest (for anesthesia) among others, [10] [12] is the S(+) enantiomer of ketamine. [5] [13] It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression.
2-Fluorodeschloroketamine. 2-Fluorodeschloroketamine (also known as 2'-Fl-2-Oxo-PCM, Fluoroketamine and 2-FDCK) is a dissociative anesthetic [1] related to ketamine. Its sale and use as a designer drug has been reported in various countries. [2][3][4] It is an analogue of ketamine where the chlorine group has been replaced by fluorine.
Psychedelia. N,N-Dimethyltryptamine (DMT or N,N-DMT) is a substituted tryptamine that occurs in many plants and animals, including humans, and which is both a derivative and a structural analog of tryptamine. [4] DMT is used as a psychedelic drug and prepared by various cultures for ritual purposes as an entheogen.
Ketamine's rise in the dance culture was most rapid in Hong Kong by the end of the 1990s. [32] Ketamine use as a recreational drug has been implicated in deaths globally, with more than 90 deaths in England and Wales in the years of 2005–2013. [37] They include accidental poisonings, drownings, traffic accidents, and suicides. [37]
Cariprazine. Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, [8] which is used in the treatment of schizophrenia, bipolar mania, [9] bipolar depression, [10] and major depressive disorder. [6]
MIRA Pharmaceuticals Inc (NASDAQ:MIRA) announced new preclinical study results for its novel oral ketamine analog, Ketamir-2. MIRA Pharmaceuticals is developing the next generation of oral ...